(Reuters) – Merck & Co Inc said on Tuesday its therapy involving cancer drug Keytruda in combination with chemotherapy met main goal of a late-stage study for treating a type of cancer of the esophagus.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Anil D’Silva)
